Workflow
Illumina(ILMN)
icon
Search documents
Illumina, Inc. (ILMN) UBS MedTech, Tools and Genomics Summit 2023 Conference (Transcript)
2023-08-17 06:28
https://reportify-1252068037.cos.ap-beijing.myqcloud.com/media/production/s_m_content_254892f25802eaac1a5d82eb4b0a9a04.html ...
Illumina(ILMN) - 2023 Q2 - Earnings Call Transcript
2023-08-10 04:08
Illumina, Inc. (NASDAQ:ILMN) Q2 2023 Results Earnings Conference Call August 9, 2023 5:00 PM ET Company Participants Salli Schwartz - Vice President of Investor Relations Charles Dadswell - Interim Chief Executive Officer and General Counsel Joydeep Goswami - Chief Financial Officer, Chief Strategy and Corporate Development Officer Conference Call Participants Puneet Souda - SVB Leerink Dan Brennan - TD Cowen Dan Arias - Stifel Financial Vijay Kumar - Evercore ISI Tejas Savant - Morgan Stanley Sung Ji Nam - ...
Illumina(ILMN) - 2024 Q2 - Quarterly Report
2023-08-09 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended July 2, 2023 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 001-35406 Illumina, Inc. (Exact name of registrant as specified in its charter) Delaware 33-0804655 (State or other jurisdiction of incorporation or ...
Illumina(ILMN) - 2024 Q1 - Quarterly Report
2023-05-04 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended April 2, 2023 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 001-35406 Illumina, Inc. (Exact name of registrant as specified in its charter) Delaware 33-0804655 (State or other jurisdiction of incorporation o ...
Illumina(ILMN) - 2023 Q1 - Earnings Call Transcript
2023-04-26 00:46
Illumina, Inc. (NASDAQ:ILMN) Q1 2023 Earnings Conference Call April 25, 2023 5:00 PM ET Company Participants Salli Schwartz - Vice President of Investor Relations Francis deSouza - President and Chief Executive Officer Joydeep Goswami - Chief Financial Officer and Chief Strategy and Corporate Development Officer Conference Call Participants Puneet Souda - SVB Securities Dan Brennan - TD Cowen Dan Arias - Stifel Vijay Kumar - Evercore ISI Tejas Savant - Morgan Stanley Julia Qin - J.P. Morgan David Westenberg ...
Illumina(ILMN) - 2022 Q3 - Earnings Call Transcript
2022-11-04 01:59
Illumina, Inc. (NASDAQ:ILMN) Q3 2022 Earnings Conference Call November 3, 2022 5:00 PM ET Company Participants Salli Schwartz - Vice President of Investor Relations Francis deSouza - President & Chief Executive Officer Joydeep Goswami - Chief Strategy & Corporate Development Officer, Interim Chief Financial Officer Conference Call Participants Dan Brennan - Cowen Vijay Kumar - Evercore ISI Dan Arias - Stifel Puneet Souda - SVB Securities Julia Qin - JPMorgan David Westenberg - Piper Sandler Michael Ryskin - ...
Illumina(ILMN) - 2022 Q1 - Earnings Call Transcript
2022-05-06 01:22
Illumina, Inc. (NASDAQ:ILMN) Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ET Company Participants Salli Schwartz - Vice President, Investor Relations Francis deSouza - President & Chief Executive Officer Sam Samad - Chief Financial Officer Conference Call Participants Dan Brennan - Cowen & Company Dan Arias - Stifel, Nicolaus Mike Ryskin - Bank of America Tejas Savant - Morgan Stanley Kyle Mikson - Canaccord Genuity David Westenberg - Piper Sandler Puneet Souda - SVB Leerink Patrick Donnelly - Citi ...